Single-arm trial reports orelabrutinib response in high-risk lymphoma
In a prospective, multicenter, single-arm phase II trial conducted at four centers in China, orelabrutinib plus R-CDOP was associated with ...
In a prospective, multicenter, single-arm phase II trial conducted at four centers in China, orelabrutinib plus R-CDOP was associated with ...
An experimental mouse and cell study found that the adamantane-nitrone hybrid TA1 reduced cerebral infarct volume from 32.97% to 14.33% ...
An L-alanine-functionalized, virus-like mesoporous silica carrier improved antibiotic delivery and therapeutic outcomes in mouse models of bacterial meningitis.
A 2026 review finds that natural products affect multiple neuroprotective and repair pathways in vascular dementia models, but mostly preclinical ...
A computational screen followed by cell-free Aβ42 assays identified four Jowiseungchungtang-derived small molecules that inhibited aggregation, with two also reducing ...
A new review details how extracellular vesicles carrying brain-derived proteins and RNAs could enable minimally invasive diagnosis of Alzheimer's, Parkinson's, ...
A review of 11 validated studies shows how ultra-sensitive analysis is reshaping efforts to measure rivastigmine, a rapidly cleared brain-targeted ...
A new review proposes that age-related remodeling of the sugar layer lining brain blood vessels could converge with galectin-3 inflammatory ...
A new conceptual framework called the Gut-Brain Homeostatic Continuum reframes Alzheimer's disease as a progressive erosion of organismal resilience driven ...
A prospective study finds that dynamic contrast-enhanced MRI detects significant vascular changes in brain metastases within four to eight weeks ...
A new review in Molecular Biology Reports details how the dietary flavonoid apigenin combats oxidative stress, neuroinflammation, mitochondrial dysfunction, and ...
A new review argues that the ubiquitin-proteasome system degrades P-glycoprotein at the blood-brain barrier, impairing amyloid-beta clearance and offering new ...
A new Oncoscience perspective maps the 2025–2026 glioblastoma clinical trial pipeline across four mechanistic domains, showing how biomarker-guided selection and ...
A new review in Pharmacia charts how magnetic nanoparticles, metal-organic frameworks, and ROS-responsive carriers are transforming targeted cancer therapy and ...
A new review argues that the bottleneck for RNAi therapies in Alzheimer's, Parkinson's and Huntington's disease is not gene silencing ...
A new review argues that recurrent mitochondrial metabolic stress, redox imbalance, and inflammatory signaling converge on the neurovascular unit to ...
A new perspective in Frontiers in Molecular Neuroscience argues that chronic circadian misalignment should be reconceptualized as a potential, modifiable ...
A neuroimaging study of 211 adults found that people with metabolic syndrome have larger choroid plexus volumes linked to low ...
A biomimetic nanoplatform cloaked in microglial cell membranes delivers carbon monoxide, manganese ions, and Gasdermin E across the blood-brain barrier ...
A new narrative review argues that ApoE4 acts as a context-dependent susceptibility modifier in cerebral small vessel disease rather than ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.